GSK (GSK) issues statement Zantac (ranitidine) litigation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to GSK (GSK) issues statement Zantac (ranitidine) litigation
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 49.47 -0.53 (1.06%)
Previous Close $50.00    52 Week High $45.58 
Open $49.04    52 Week Low $37.82 
Day High $49.49    P/E N/A 
Day Low $48.86    EPS $0.00 
Volume 2,409,894